China biotech start-up Lianbio files for US IPO LianBio, a two-year-old Chinese biotech start-up incubated by life sciences investor Perceptive Advisors, has filed for a US IPO. The three largest institutional investors are Perceptive with 62.4%, RA Capital with 7.2%, and BridgeBio Pharma with 5.8%, according to the prospectus. US-based BridgeBio is also a strategic partner, giving… Latest News [China Renaissance hits first close on flagship US dollar fund] Huaxing Growth Capital, a new economy-focused private equity division of China Renaissance, has reached the first close on its fourth US dollar-denominated fund of $550 million. [East, Vulcan lead $15m Series A for Singapore's Qapita] Qapita, a Singapore-based provider of software used by start-ups to manage cap tables and employee stock ownership plans (ESOP), has raised $15 million in Series A funding. [Allegro sells New Zealand retailer to Pencarrow] Australian turnaround investor Allegro Funds has sold The Interiors Group – a New Zealand-based home interiors retailer formerly known as Carpet Court – to Pencarrow Private Equity. [India cloud kitchen player Rebel Foods raises $175m] India-based cloud kitchen operator Rebel Foods has raised $175 million in Series F funding, led by Qatar Investment Authority (QIA), at a valuation of $1.4 billion.
CNY - Chinese Yuan Renminbi